Next Article in Journal
Current State and Future Challenges for PI3K Inhibitors in Cancer Therapy
Next Article in Special Issue
Real-World Effectiveness, Safety, and Health-Related Quality of Life in Patients Receiving Adjuvant Nivolumab for Melanoma in Belgium and Luxembourg: Results of PRESERV MEL
Previous Article in Journal
Mechanism-Driven and Clinically Focused Development of Botanical Foods as Multitarget Anticancer Medicine: Collective Perspectives and Insights from Preclinical Studies, IND Applications and Early-Phase Clinical Trials
Previous Article in Special Issue
Application of Electronic Health Record Text Mining: Real-World Tolerability, Safety, and Efficacy of Adjuvant Melanoma Treatments

Article Versions Notes

Cancers 2023, 15(3), 702;
Action Date Notes Link
article pdf uploaded. 23 January 2023 16:00 CET Version of Record
article supplementary file uploaded. 23 January 2023 16:00 CET -
article xml file uploaded 6 February 2023 11:37 CET Original file -
article xml uploaded. 6 February 2023 11:37 CET Update
article pdf uploaded. 6 February 2023 11:37 CET Updated version of record
article html file updated 6 February 2023 11:39 CET Original file -
article html file updated 8 March 2023 01:51 CET Update
Back to TopTop